# Origami Robotics -- Elad Gil Evaluation

The first thing I notice is the competitive landscape, and it tells me everything about the market structure. Physical Intelligence has raised $1.1 billion and is valued at $5.6 billion. Figure AI is at $39 billion. Sanctuary AI, Mimic, Flexion -- the list runs deep. Robotic manipulation is not a non-obvious market. It is arguably the single most consensus-hot market in venture capital right now, behind only foundation model infrastructure. When I look at my best investments -- PagerDuty, Gusto, Checkr, even Coinbase early on -- the defining characteristic was that other investors dismissed the market as too boring, too niche, or too unfamiliar. Nobody is dismissing robotic manipulation in 2026. Every major fund has a thesis here. That structural feature of the market -- its obviousness -- is what makes asymmetric returns unlikely for a pre-seed entrant.

The bull case deserves genuine engagement because the technical insight is real. Daniel Xie's PhD at CMU's CLAW Lab is directly on embodiment gap reduction in dexterous manipulation -- this isn't a founder pivoting into robotics from an adjacent field, this is someone whose published research IS the company. The matched-hardware architectural choice (co-designing the data-collection device and the robot hand so kinematics align perfectly) addresses a well-documented bottleneck in real-world policy transfer. If that approach turns out to be the right one -- if sim-to-real transfer and hardware-agnostic foundation models hit a wall that embodiment-matched data collection avoids -- Origami could have a genuine technical moat. The hand-only form factor is also a narrower, cheaper bet than full humanoid platforms, which means faster iteration cycles and lower capital requirements per unit. For this to work, you'd need the matched-hardware thesis to prove decisively superior AND for the larger players to be too committed to their existing architectures to pivot. That's a real scenario, but it's a narrow one.

The problem is that this company requires multiple sequential miracles. Miracle one: build custom high-DOF direct-drive hardware at manufacturing quality. Miracle two: solve the chicken-and-egg data collection problem -- factories won't host unproven hardware, but the model needs factory data to prove itself. Miracle three: train a general "manipulate anything" model that actually works across diverse tasks. Miracle four: execute enterprise sales into manufacturing and logistics, which are notoriously long-cycle, relationship-driven channels. When I see a plan that requires four sequential breakthroughs, compounding small odds, I pass. And the capital intensity makes it worse -- hardware iteration cycles require tooling, manufacturing partners, and physical testing infrastructure that $500K doesn't begin to cover. When I backed Anduril's $450 million Series D, the structural logic was that Google's Project Maven cancellation had created a vacuum with no credible startup competitor. In dexterous manipulation, there are five well-funded credible competitors, and PI alone has two thousand times Origami's capital.

Distribution is the dimension I care about most after market structure, and there's nothing here. The dossier describes a "Tesla-like data flywheel" aspiration, but Tesla had millions of cars on the road generating data because people wanted to buy the car independent of its data-collection function. Origami has no product generating pull. The stated go-to-market -- deploy hardware into factories, collect data, train models, sell automation back -- is a strategy description, not a distribution plan. Who are the first three factories? What's the relationship? Is there an LOI? There's no evidence the founders have thought concretely about distribution at all, and the plan reads more like a research proposal than a startup with go-to-market urgency. I've said it many times: almost every company that's reached tens of billions in market cap was aggressive about distribution from its earliest days. The absence of any distribution signal here is concerning.

The technology timing is reasonable in the abstract -- visuomotor learning has crossed capability thresholds, actuator costs are declining, manufacturing labor shortages are real. But this "why now" is visible to everyone, which is exactly why PI, Figure, Sanctuary, and Mimic all exist. The CMU LEAP Hand project has already open-sourced a low-cost dexterous hand under $2,000, which means the hardware principle Origami builds on is already in the public domain. I also note two execution risk signals: Daniel's LinkedIn still lists him as a PhD student, and Ryan's LinkedIn still lists Ground Robotics as his primary affiliation. At pre-seed, founder focus is everything -- competing commitments at this stage are a real concern, not a technicality. The research pedigree is genuine but the startup execution evidence is thin.

This is a competent team with relevant technical depth pursuing a real problem with a defensible architectural insight. In a different competitive landscape -- if dexterous manipulation were a "too boring" market that other investors were ignoring -- I'd look more closely. But the market structure makes this a consensus bet at a stage where the company cannot out-capitalize its competitors, the plan requires multiple miracles, and there's no distribution moat forming. I pass.

### Dimension Scores

| Criterion | Score |
|-----------|-------|
| Non-Obvious Market at Structural Inflection | 10/35 |
| Product-to-Distribution Trajectory | 9/25 |
| Single-Miracle Operational Clarity | 5/15 |
| Founder Execution Velocity | 6/15 |
| Technology Cycle Positioning | 5/10 |
| **Total** | **35/100** |

**Total Score: 35/100** (Pass)
